MidFirst Bank’s Takeda Pharmaceutical TAK Stock Holding History

MidFirst Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$385	Hold	24	–	–	﹤0.01%	867
2026 Q1	$444	Buy	+24	New	+$421	﹤0.01%	835

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MAP

Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

MidFirst Bank's TAK Position: Q2 2026 in Review

MidFirst Bank held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 24 shares worth $385. The position accounts for ﹤0.01% of the portfolio, ranked #867.

MidFirst Bank first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $444 in Q1 2026. 304 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

MidFirst Bank held 24 shares of Takeda Pharmaceutical worth $385 as of Q2 2026.
MidFirst Bank left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #867 holding.
MidFirst Bank first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
MidFirst Bank's Takeda Pharmaceutical position peaked at $444 in Q1 2026.
304 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.